Abstract: A silybin injection contains silybin, sulfobutyl ether-?-cyclodextrin, an organic solvent for injection, a pH regulator, and may further contain a co-solvent, a lyophilization bulking agent, and water for injection.

Abstract: Disclosed are a photovoltaic system and its rapid shutdown method. The photovoltaic system includes a photovoltaic array including a photovoltaic array panel and a shutdown device, a junction box and an inverter, the shutdown device is electrically connected to the photovoltaic array panel and is connected to the inverter; the photovoltaic system further includes a shutdown device controller, which is coupled to the high voltage wires, and is configured for receiving a first detection signal reflecting a state of the AC side of the inverter, determining whether the AC side of the inverter is in a power-off state, outputting a first power-off signal when the AC side of the inverter is in the power-off state, and transferring the first power-off signal to the shutdown device; and the shutdown device receives the first power-off signal and prohibits the electric energy from transferring to the inverter.

Abstract: An inverter includes a first bridge leg, first to fourth MOSFET switches; a second bridge leg, connected in parallel with the first bridge leg, and fifth to eighth MOSFET switches; a third bridge leg, electrically coupled between a first node and a second node, and ninth to twelfth MOSFET switches; a first diode, connected in parallel with the anti-series connected first and second MOSFET switches; a second diode, connected in parallel with the anti-series connected third and fourth MOSFET switches; a third diode, connected in parallel with the anti-series connected fifth and sixth MOSFET switches; a fourth diode, connected in parallel with the anti-series connected seventh and eighth MOSFET switches; a fifth diode, connected in parallel with the anti-series connected ninth and tenth MOSFET switches; a sixth diode, connected in parallel with the anti-series connected eleventh and twelfth MOSFET switches.

Abstract: A temsirolimus liposome and preparation method thereof is provided. The formulation of the present invention contains temsirolimus, a phospholipid, a PEGylated phospholipid, and can further contain cholesterol, a stabilizer and a lyoprotectant. In view of the unique physicochemical properties of temsirolimus, the present invention performed a matching study on the formulation composition and preparation process, and developed a temsirolimus liposome, preferably a lyophilized powder injection, which is safe, stable in quality, simple in preparation process, and can be industrially produced. The preparation overcomes the disadvantages of poor safety, stability and the like in the existing preparations, establishing a solid foundation for the further study and application of temsirolimus in the anti-tumor field.

Abstract: Provided in the present invention is a cabazitaxel fat emulsion injection, wherein the cabazitaxel fat emulsion injection contains cabazitaxel, a medium chain triglyceride for injection, and lecithin. Also provided in the present invention are the method for preparing the cabazitaxel fat emulsion injection and the use thereof in preparing a drug for treating prostate cancer.

Abstract: A photovoltaic power generation system includes a plurality of photovoltaic arrays, a plurality of shutdown units and an inverter. The shutdown unit is adjacent to the corresponding photovoltaic array, connected in parallel with the corresponding photovoltaic array, and electrically connected to the inverter via high voltage wires; the photovoltaic power generation system further includes a control unit configured to receive a detection signal indicating a state of the AC side of the inverter, monitor whether the AC side of the inverter is in a power-off state according to the detection signal, and generate a first power-off signal when the AC side of the inverter is in the power-off state; and the shutdown units are configured to receive the first power-off signal, and stop a power transmission from the photovoltaic arrays to the inverter according to the first power-off signal.

Abstract: A silybin injection contains silybin, sulfobutyl ether-?-cyclodextrin, an organic solvent for injection and may further contain a co-solvent, a lyophilization proppant, a pH regulator, water for injection and the like.

Abstract: An inverter includes a first bridge leg, first to fourth MOSFET switches; a second bridge leg, connected in parallel with the first bridge leg, and fifth to eighth MOSFET switches; a third bridge leg, electrically coupled between a first node and a second node, and ninth to twelfth MOSFET switches; a first diode, connected in parallel with the anti-series connected first and second MOSFET switches; a second diode, connected in parallel with the anti-series connected third and fourth MOSFET switches; a third diode, connected in parallel with the anti-series connected fifth and sixth MOSFET switches; a fourth diode, connected in parallel with the anti-series connected seventh and eighth MOSFET switches; a fifth diode, connected in parallel with the anti-series connected ninth and tenth MOSFET switches; a sixth diode, connected in parallel with the anti-series connected eleventh and twelfth MOSFET switches.

Abstract: Disclosed are a photovoltaic system and its rapid shutdown method. The photovoltaic system includes a photovoltaic array including a photovoltaic array panel and a shutdown device, a junction box and an inverter, the shutdown device is electrically connected to the photovoltaic array panel and is connected to the inverter; the photovoltaic system further includes a shutdown device controller, which is coupled to the high voltage wires, and is configured for receiving a first detection signal reflecting a state of the AC side of the inverter, determining whether the AC side of the inverter is in a power-off state, outputting a first power-off signal when the AC side of the inverter is in the power-off state, and transferring the first power-off signal to the shutdown device ; and the shutdown device receives the first power-off signal and prohibits the electric energy from transferring to the inverter.

Abstract: Disclosed are a method, device and terminal for implementing rotation of a floating window. The method comprises: providing, by user equipment, a picture container supporting a rotation attribute for a user interface (UI) floating window view; adding the UI floating window view to the picture container; when the orientation is changed, acquiring a rotation angle of the UI floating window view, redrawing the rotated UI floating window view, and acquiring a rotation reduction matrix; and when a user click event is detected, performing rotation reduction conversion on the coordinates at the user click position. The technical solution of the present invention has the beneficial effects of low calculation quantity, high processing efficiency and natural appearance of a floating window UI component.

Abstract: The invention relates to a preparation of taxanes for intravenous administration consisting of a drug solution and an emulsion. The drug solution consists of paclitaxel or docetaxel, a pH regulator and an organic solvent for injection. The emulsion includes a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When used, the drug solution at the clinical dosage can be added and evenly mixed in the emulsion to perform intravenous drip directly; or the drug solution at the clinical dosage can also be firstly added into the emulsion with no less than 5 times volume of the drug solution and then a predetermined amount of normal saline or glucose solution for injection is added to perform intravenous drip. The preparation of the present invention does not contain solubilizer.

Abstract: Disclosed are a method, device and terminal for implementing rotation of a floating window. The method comprises: providing, by user equipment, a picture container supporting a rotation attribute for a user interface (UI) floating window view; adding the UI floating window view to the picture container; when the orientation is changed, acquiring a rotation angle of the UI floating window view, redrawing the rotated UI floating window view, and acquiring a rotation reduction matrix; and when a user click event is detected, performing rotation reduction conversion on the coordinates at the user click position. The technical solution of the present invention has the beneficial effects of low calculation quantity, high processing efficiency and natural appearance of a floating window UI component.

Abstract: A pharmaceutical solution of taxanes, its preparation method, a composition comprising said solution and its pharmaceutical combination package are disclosed. Said pharmaceutical solution comprises taxanes, a pH regulator and a solvent, wherein the pH regulator is a water-soluble acid.

Abstract: The present invention relates to the field of computers, and disclosed are a method, device, and system for encrypting and decrypting an image. The method for encrypting an image includes: encrypting a preset size of header data of a to-be-encrypted image, and obtaining an encrypted data corresponding to the header data; determining a storage location for saving the encrypted data, saving the encrypted data in the storage location, and acquiring an offset for saving the encrypted data; and placing the encryption identifier and the offset in a storage area of the preset size of the to-be-encrypted image, so as to encrypt the to-be-encrypted image. The system includes: a device for encrypting an image and a device for decrypting an image. The present invention is capable of improving the speed and efficiency of encrypting and decrypting an image.

Abstract: The present invention relates to the field of medical technology. More specifically, the present invention relates to a preparation of taxanes for intravenous administration, which consists of two parts: a drug solution and an emulsion. Said drug solution consists of paclitaxel or docetaxel, a pH regulator and a solvent for injection, wherein said solvent for injection is an organic solvent. Said emulsion includes a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When used, the drug solution at the clinical dosage can be added and mixed homogeneously in the emulsion to perform intravenous drip directly; or the drug solution at the clinical dosage can also be firstly added into the emulsion with no less than 5 times volume of the drug solution and then a predetermined amount of normal saline or glucose solution for injection is added to perform intravenous drip.

Abstract: The present invention relates to the field of computers, and disclosed are a method, device, and system for encrypting and decrypting an image. The method for encrypting an image includes: encrypting a preset size of header data of a to-be-encrypted image, and obtaining an encrypted data corresponding to the header data; determining a storage location for saving the encrypted data, saving the encrypted data in the storage location, and acquiring an offset for saving the encrypted data; and placing the encryption identifier and the offset in a storage area of the preset size of the to-be-encrypted image, so as to encrypt the to-be-encrypted image. The system includes: a device for encrypting an image and a device for decrypting an image. The present invention is capable of improving the speed and efficiency of encrypting and decrypting an image.

Abstract: The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, and can be used to treat Helicobacter Pylori-induced diseases of digestive system, such as gastritis, gastric ulcer, etc., with easy availability of raw materials, simple preparations, prominent effects, and less side-effect.

Abstract: The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, and can be used to treat Helicobacter Pylori -induced diseases of digestive system, such as gastritis, gastric ulcer, etc., with easy availability of raw materials, simple preparations, prominent effects, and less side-effect.

Abstract: The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine Chenopodium ambrosioides L. are prepared by conventional methods for the extraction of volatile oil, and can be used to treat Helicobacter Pylori-induced diseases of digestive system, such as gastritis, gastric ulcer, etc., with easy availability of raw materials, simple preparations, prominent effects, and less side-effect.

Abstract: A pharmaceutical solution of taxanes, its preparation method, a composition comprising said solution and its pharmaceutical combination package are disclosed. Said pharmaceutical solution comprises taxanes, a pH regulator and a solvent, wherein the pH regulator is a water-soluble acid.